Home > Compound List > Product Information
Loperamide_Molecular_structure_CAS_53179-11-6)
Click picture or here to close

Loperamide

Catalog No. DB00836 Name DrugBank
CAS Number 53179-11-6 Website http://www.ualberta.ca/
M. F. C29H33ClN2O2 Telephone (780) 492-3111
M. W. 477.03752 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 715

SYNONYMS

IUPAC name
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide
IUPAC Traditional name
loperamide
Brand Name
Imodium
Diarr-Eze
Apo-Loperamide
Loperacap
Imodium A-D
Imodium A-D Caplets
Ioperamide
Kaopectate II
Loperamida [INN-Spanish]
Loperamide HCL
Loperamidum [INN-Latin]
Maalox Anti-Diarrheal
Nu-Loperamide
PMS-Loperamide
Rho-Loperamide
Pepto Diarrhea Control

DATABASE IDS

CAS Number 53179-11-6
PubChem SID 46504591
PubChem CID 3955

PROPERTIES

Hydrophobicity(logP) 5.5
Solubility Slight

DETAILS

Description (English)
Item Information
Drug Groups approved
Description One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally. [PubChem]
Indication For the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease or gastroenteritis. Also used for reducing the volume of discharge from ileostomies.
Pharmacology Loperamide is a synthetic anti-diarrheal indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease. Loperamide is also indicated for reducing the volume of discharge from ileostomies. In man, Loperamide prolongs the transit time of the intestinal contents. It reduces the daily fecal volume, increases the viscosity and bulk density, and diminishes the loss of fluid and electrolytes. Tolerance to the antidiarrheal effect has not been observed. Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines; it does not affect the central nervous system like other opioids. It works specifically by decreasing the activity of the myenteric plexus which decreases the motility of the circular and longitudinal smooth muscles of the intestinal wall. This increases the amount of time substances stay in the intestine, allowing for more water to be absorbed out of the fecal matter. Loperamide also decreases colonic mass movements and suppresses the gastrocolic reflex.
Toxicity Oral, mouse: LD50 = 105 mg/kg. Symptoms of overdose include constipation, drowsiness, lethargy, and nausea.
Affected Organisms
Humans and other mammals
Biotransformation Hepatic
Absorption Not significantly absorbed from the gut
Half Life 9.1 to 14.4 hours (average 10.8 hours)
Protein Binding 97%
Elimination Excretion of the unchanged loperamide and its metabolites mainly occurs through the feces.
External Links
Wikipedia
RxList
PDRhealth
Drugs.com

REFERENCES